| Financial Year |
March 31 2023 |
| Monetary Funds |
2,438,615,898.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
159,250,506.08 |
| Accounts Receivable |
1,302,076,863.55 |
| Advances to Suppliers |
517,197,591.31 |
| Other Receivables |
49,971,050.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,045,625,755.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,027,457.65 |
| Other Current Assets |
22,394,876.16 |
| Total Current Assets |
8,821,513,121.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
362,529,651.94 |
| Long-term Equity Investment |
188,300,000.00 |
| Investment Properties |
51,352,868.35 |
| Fixed Assetes |
2,159,691,454.95 |
| Under-construction Projects |
162,216,862.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
199,651,145.47 |
| R&D expenses |
3,607,509.88 |
| Goodwill |
263,334,426.72 |
| Long-Term Deferred and Prepaid Expenses |
1,889,761.17 |
| Deferred Income Tax Assets |
27,676,423.10 |
| Other Non-Current Assets |
412,777,540.75 |
| Sub-Total of Non-Current Assets |
3,899,128,413.93 |
| Total Assets |
12,720,641,535.71 |
| Short-Term Loans |
2,665,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,766,170,936.42 |
| Accounts Payable |
1,433,144,781.89 |
| Accounts Received In Advance |
8,670,863.59 |
| Employee Compensation Payable |
31,279,527.92 |
| Taxes Payable |
25,442,413.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
60,913,208.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,713,258.28 |
| Other Current Liabilities |
236,100,887.36 |
| Sub-Total of Current Liabilities |
8,066,920,589.41 |
| Long-term Loans |
1,020,563,848.68 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
42,032,852.28 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
180,810,137.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,271,175,850.81 |
| Total Liabilities |
9,338,096,440.22 |
| Paid-In Capital(Or Share Stock) |
1,306,291,798.00 |
| Capital Surplus |
2,517,010,716.62 |
| Surplus Reserve |
114,329,807.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-772,947,586.44 |
| Minority Stockholder's Interest |
211,527,612.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,171,017,483.26 |
| Owner's Equity（Stockholder's Equity） |
3,382,545,095.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,720,641,535.71 |
